{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:36Z","timestamp":1790352516394,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA108961"],"award-info":[{"award-number":["P50 CA108961"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS086853"],"award-info":[{"award-number":["NS086853"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008222","name":"Ben and Catherine Ivy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11060-015-1981-0","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T15:41:20Z","timestamp":1447170080000},"page":"397-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway"],"prefix":"10.1007","volume":"126","author":[{"given":"Harshil D.","family":"Dhruv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Tomboc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Tuncali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Berens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan L.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"issue":"Suppl 4","key":"1981_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011. Neuro Oncol 16(Suppl 4):iv1\u2013iv63. doi:\n                    10.1093\/neuonc\/nou223","journal-title":"Neuro Oncol"},{"issue":"11","key":"1981_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneurol.2009.159","volume":"5","author":"AD Norden","year":"2009","unstructured":"Norden AD, Drappatz J, Wen PY (2009) Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol 5(11):610\u2013620. doi:\n                    10.1038\/nrneurol.2009.159","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"1981_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. doi:\n                    10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"5","key":"1981_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiation Oncology G, National Cancer Institute of Canada Clinical Trials G (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466. doi:\n                    10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"issue":"4","key":"1981_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1586\/14737159.6.4.613","volume":"6","author":"B Salhia","year":"2006","unstructured":"Salhia B, Tran NL, Symons M, Winkles JA, Rutka JT, Berens ME (2006) Molecular pathways triggering glioma cell invasion. Expert Rev Mol Diagn 6(4):613\u2013626. doi:\n                    10.1586\/14737159.6.4.613","journal-title":"Expert Rev Mol Diagn"},{"issue":"8","key":"1981_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1158\/1541-7786.MCR-13-0008","volume":"11","author":"JC Loftus","year":"2013","unstructured":"Loftus JC, Dhruv H, Tuncali S, Kloss J, Yang Z, Schumacher CA, Cao B, Williams BO, Eschbacher JM, Ross JT, Tran NL (2013) TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance. Mol Cancer Res 11(8):865\u2013874. doi:\n                    10.1158\/1541-7786.MCR-13-0008","journal-title":"Mol Cancer Res"},{"issue":"1","key":"1981_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0165-3806(03)00101-9","volume":"143","author":"T Hisaoka","year":"2003","unstructured":"Hisaoka T, Morikawa Y, Kitamura T, Senba E (2003) Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain. Brain Res Dev Brain Res 143(1):105\u2013109","journal-title":"Brain Res Dev Brain Res"},{"issue":"4","key":"1981_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/glia.10323","volume":"45","author":"T Hisaoka","year":"2004","unstructured":"Hisaoka T, Morikawa Y, Kitamura T, Senba E (2004) Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing olfactory system. Glia 45(4):313\u2013324. doi:\n                    10.1002\/glia.10323","journal-title":"Glia"},{"issue":"1","key":"1981_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/geno.1999.5979","volume":"62","author":"S Hu","year":"1999","unstructured":"Hu S, Tamada K, Ni J, Vincenz C, Chen L (1999) Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily. Genomics 62(1):103\u2013107. doi:\n                    10.1006\/geno.1999.5979","journal-title":"Genomics"},{"issue":"7","key":"1981_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ng.601","volume":"42","author":"JX Bei","year":"2010","unstructured":"Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, Chen LZ, Feng QS, Low HQ, Zhang H, He F, Tai ES, Kang T, Liu ET, Liu J, Zeng YX (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 42(7):599\u2013603. doi:\n                    10.1038\/ng.601","journal-title":"Nat Genet"},{"issue":"8","key":"1981_CR11","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/ijc.28839","volume":"135","author":"S Schon","year":"2014","unstructured":"Schon S, Flierman I, Ofner A, Stahringer A, Holdt LM, Kolligs FT, Herbst A (2014) Beta-catenin regulates NF-kappaB activity via TNFRSF19 in colorectal cancer cells. Int J Cancer 135(8):1800\u20131811. doi:\n                    10.1002\/ijc.28839","journal-title":"Int J Cancer"},{"issue":"6","key":"1981_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/ijc.22367","volume":"120","author":"RA Spanjaard","year":"2007","unstructured":"Spanjaard RA, Whren KM, Graves C, Bhawan J (2007) Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target. Int J Cancer 120(6):1304\u20131310. doi:\n                    10.1002\/ijc.22367","journal-title":"Int J Cancer"},{"issue":"11","key":"1981_CR13","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1158\/1541-7786.MCR-10-0334","volume":"8","author":"VM Paulino","year":"2010","unstructured":"Paulino VM, Yang Z, Kloss J, Ennis MJ, Armstrong BA, Loftus JC, Tran NL (2010) TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res 8(11):1558\u20131567. doi:\n                    10.1158\/1541-7786.MCR-10-0334","journal-title":"Mol Cancer Res"},{"issue":"Suppl 2","key":"1981_CR14","first-page":"S29","volume":"12","author":"R Mielke","year":"1998","unstructured":"Mielke R, Moller HJ, Erkinjuntti T, Rosenkranz B, Rother M, Kittner B (1998) Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. Alzheimer Dis Assoc Disord 12(Suppl 2):S29\u2013S35","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Suppl 1","key":"1981_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000051188","volume":"9","author":"M Rother","year":"1998","unstructured":"Rother M, Erkinjuntti T, Roessner M, Kittner B, Marcusson J, Karlsson I (1998) Propentofylline in the treatment of Alzheimer\u2019s disease and vascular dementia: a review of phase III trials. Dement Geriatr Cogn Disord 9(Suppl 1):36\u201343","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"1981_CR16","doi-asserted-by":"publisher","first-page":"e37955","DOI":"10.1371\/journal.pone.0037955","volume":"7","author":"VL Jacobs","year":"2012","unstructured":"Jacobs VL, Liu Y, De Leo JA (2012) Propentofylline targets TROY, a novel microglial signaling pathway. PLoS ONE 7(5):e37955. doi:\n                    10.1371\/journal.pone.0037955","journal-title":"PLoS ONE"},{"key":"1981_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-3-642-13443-2_8","volume":"200","author":"S Sweitzer","year":"2011","unstructured":"Sweitzer S, De Leo J (2011) Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol 200:235\u2013250. doi:\n                    10.1007\/978-3-642-13443-2_8","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"1981_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/neuonc\/nor194","volume":"14","author":"VL Jacobs","year":"2012","unstructured":"Jacobs VL, Landry RP, Liu Y, Romero-Sandoval EA, De Leo JA (2012) Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol 14(2):119\u2013131. doi:\n                    10.1093\/neuonc\/nor194","journal-title":"Neuro Oncol"},{"issue":"2","key":"1981_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1215\/S1152851704000821","volume":"7","author":"C Giannini","year":"2005","unstructured":"Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, James CD (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol 7(2):164\u2013176. doi:\n                    10.1215\/S1152851704000821","journal-title":"Neuro Oncol"},{"issue":"3","key":"1981_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/1535-7163.MCT-06-0691","volume":"6","author":"JN Sarkaria","year":"2007","unstructured":"Sarkaria JN, Yang L, Grogan PT, Kitange GJ, Carlson BL, Schroeder MA, Galanis E, Giannini C, Wu W, Dinca EB, James CD (2007) Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel. Mol Cancer Ther 6(3):1167\u20131174. doi:\n                    10.1158\/1535-7163.MCT-06-0691","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"1981_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1593\/neo.05190","volume":"7","author":"WS McDonough","year":"2005","unstructured":"McDonough WS, Tran NL, Berens ME (2005) Regulation of glioma cell migration by serine-phosphorylated P311. Neoplasia 7(9):862\u2013872","journal-title":"Neoplasia"},{"issue":"7391","key":"1981_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jane-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P Jr, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603\u2013607. doi:\n                    10.1038\/nature11003","journal-title":"Nature"},{"issue":"5","key":"1981_CR23","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315\u20132319. doi:\n                    10.1038\/nprot.2006.339","journal-title":"Nat Protoc"},{"issue":"3","key":"1981_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nprot.2006.466","volume":"2","author":"A Albini","year":"2007","unstructured":"Albini A, Benelli R (2007) The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc 2(3):504\u2013511. doi:\n                    10.1038\/nprot.2006.466","journal-title":"Nat Protoc"},{"issue":"30","key":"1981_CR25","doi-asserted-by":"publisher","first-page":"21887","DOI":"10.1074\/jbc.M113.468686","volume":"288","author":"SP Fortin Ensign","year":"2013","unstructured":"Fortin Ensign SP, Mathews IT, Eschbacher JM, Loftus JC, Symons MH, Tran NL (2013) The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2. J Biol Chem 288(30):21887\u201321897. doi:\n                    10.1074\/jbc.M113.468686","journal-title":"J Biol Chem"},{"issue":"22","key":"1981_CR26","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1158\/0008-5472.CAN-04-2097","volume":"64","author":"YY Chuang","year":"2004","unstructured":"Chuang YY, Tran NL, Rusk N, Nakada M, Berens ME, Symons M (2004) Role of synaptojanin 2 in glioma cell migration and invasion. Cancer Res 64(22):8271\u20138275. doi:\n                    10.1158\/0008-5472.CAN-04-2097","journal-title":"Cancer Res"},{"issue":"53","key":"1981_CR27","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.1038\/sj.onc.1208909","volume":"24","author":"AY Chan","year":"2005","unstructured":"Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M (2005) Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 24(53):7821\u20137829. doi:\n                    10.1038\/sj.onc.1208909","journal-title":"Oncogene"},{"issue":"4","key":"1981_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.18632\/oncotarget.969","volume":"4","author":"RE Kast","year":"2013","unstructured":"Kast RE, Boockvar JA, Bruning A, Cappello F, Chang WW, Cvek B, Dou QP, Duenas-Gonzalez A, Efferth T, Focosi D, Ghaffari SH, Karpel-Massler G, Ketola K, Khoshnevisan A, Keizman D, Magne N, Marosi C, McDonald K, Munoz M, Paranjpe A, Pourgholami MH, Sardi I, Sella A, Srivenugopal KS, Tuccori M, Wang W, Wirtz CR, Halatsch ME (2013) A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget 4(4):502\u2013530","journal-title":"Oncotarget"},{"issue":"6","key":"1981_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.3595","volume":"20","author":"SM Strittmatter","year":"2014","unstructured":"Strittmatter SM (2014) Overcoming drug development bottlenecks with repurposing: old drugs learn new tricks. Nat Med 20(6):590\u2013591. doi:\n                    10.1038\/nm.3595","journal-title":"Nat Med"},{"issue":"5","key":"1981_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000106650","volume":"8","author":"J Marcusson","year":"1997","unstructured":"Marcusson J, Rother M, Kittner B, Rossner M, Smith RJ, Babic T, Folnegovic-Smalc V, Moller HJ, Labs KH (1997) A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. Dement Geriatr Cogn Disord 8(5):320\u2013328","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"Pt 21","key":"1981_CR31","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1242\/jcs.00712","volume":"116","author":"AM Joy","year":"2003","unstructured":"Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T, Berens ME (2003) Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116(Pt 21):4409\u20134417. doi:\n                    10.1242\/jcs.00712","journal-title":"J Cell Sci"},{"issue":"10","key":"1981_CR32","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1200\/JCO.2005.03.089","volume":"23","author":"F Lefranc","year":"2005","unstructured":"Lefranc F, Brotchi J, Kiss R (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23(10):2411\u20132422. doi:\n                    10.1200\/JCO.2005.03.089","journal-title":"J Clin Oncol"},{"issue":"12","key":"1981_CR33","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.2174\/138920112803341798","volume":"13","author":"C Zhan","year":"2012","unstructured":"Zhan C, Lu W (2012) The blood-brain\/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery. Curr Pharm Biotechnol 13(12):2380\u20132387","journal-title":"Curr Pharm Biotechnol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1981-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1981-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:20:00Z","timestamp":1589700000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1981-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1981"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1981-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]},"assertion":[{"value":"23 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}